)
Visual
test
Bioatla
Bioatla (BCAB) investor relations material
Bioatla Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary30 Jan, 2026
Executive summary
Special Meeting will be held virtually to vote on a merger with a wholly owned subsidiary, effecting a 1-for-50 share consolidation to increase the per-share price and regain Nasdaq compliance.
The Board recommends voting in favor of both the Merger Proposal and the Adjournment Proposal.
The merger aims to maintain or reinstate Nasdaq listing, improve trading liquidity, and align governance with Delaware law.
If the Merger Proposal fails, the company risks delisting, reduced liquidity, and may consider alternative strategic transactions.
Voting matters and shareholder proposals
Proposal One: Approve and adopt the Agreement and Plan of Merger for a 1-for-50 share consolidation.
Proposal Two: Authorize adjournment of the meeting to solicit additional proxies if needed.
Both proposals are considered routine matters and require majority approval.
Stockholders of record as of February 2, 2026, are eligible to vote, with one vote per share.
Stockholder proposals for the 2026 annual meeting must be submitted by December 25, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
Directors and officers before the merger will continue in their roles after the merger.
The Amended and Restated Certificate of Incorporation will remove supermajority requirements for certain amendments, defaulting to Delaware law standards.
The board is authorized to fill vacancies and set the number of directors.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebSKEL
NAV per share reached ISK 22.4, profit was ISK 4,297m, and a ISK 6,000m dividend was paid. - 5 FebCRNO
Advancing HDAC inhibitors for rare cardiopulmonary diseases, targeting major market and partnership milestones. - 5 Feb035760
Operating profit doubled YOY in Q4 2025, led by digital and global content growth. - 5 Feb033780
Record revenue, profit, and shareholder returns driven by global expansion and real estate growth. - 5 FebCMS
2025 adjusted EPS up 8%+ to $3.61, beating guidance, with a $24B capital plan and higher 2026 outlook. - 5 FebBTU
Q4 net income fell, but Centurion ramp-up and U.S. demand support future growth. - 5 FebFGA
Record Q3 revenue and strong backlog support positive outlook despite operational risks. - 5 FebDIS
Strong market, young fleet, and disciplined growth support high returns and positive 2026 outlook. - 5 FebHP
EBITDA beat expectations, margins held, and $260M debt repaid despite a $97M net loss. - 5 FebAPOLLOTYRE
Record revenue, profit growth, expansion plans, and improved financials mark Q3 FY26.
Next Bioatla earnings date
Q4 202525 Mar, 2026
Bioatla
Next Bioatla earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bioatla Inc is a clinical-stage biopharmaceutical company specializing in the development of novel monoclonal antibody and cell-based therapeutics for the treatment of solid tumor cancers. Utilizing its proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO) platforms, Bioatla is focused on creating therapies with improved selectivity for the tumor microenvironment, potentially enhancing safety and therapeutic efficacy. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage